 Thank you. Thank you all for joining us. Well, I want to start, Michael, with you. You heard the previous two or three conversations this morning, and you're a data guy. I was wondering if you, when you look at IQVIA's numbers on the shortage crisis, what do you find is behind the drug shortages that we've been experiencing, and does it again